Abstract
Ionotropic glutamate receptors (iGluRs) play a critical role in normal brain function and neurodegenerative diseases. Development of light-dependent compounds would enable studies of iGluRs within intact mammalian neural tissue, as light is noninvasive and can be applied with high spatiotemporal precision. Here we develop a potent photochromic antagonist that selectively targets the Ca2+ permeable AMPA-type of iGuRs, thus providing an important tool to study the contribution of AMPA-type iGluRs on neuronal activity.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Azo Compounds / chemistry
-
Azo Compounds / pharmacology*
-
Calcium / metabolism*
-
Cells, Cultured
-
Female
-
Light
-
Models, Molecular
-
Molecular Structure
-
Neurotransmitter Agents / chemistry
-
Neurotransmitter Agents / pharmacology*
-
Oocytes / cytology
-
Oocytes / drug effects
-
Oocytes / metabolism*
-
Polyamines / chemistry
-
Rats
-
Receptors, AMPA / antagonists & inhibitors*
-
Structure-Activity Relationship
-
Xenopus laevis
Substances
-
Azo Compounds
-
Neurotransmitter Agents
-
Polyamines
-
Receptors, AMPA
-
azobenzene
-
Calcium
-
glutamate receptor ionotropic, AMPA 1